Iolyx Therapeutics
Latest round
- Series B
Last raised
- Dec 2025
Total raised
- $15M
Investors
- 2
About Iolyx Therapeutics
Founded in 2021 and headquartered in Burlingame, California, Iolyx Therapeutics, Inc. focuses on developing therapies for ocular conditions.Iolyx Therapeutics develops therapies targeting ocular diseases, including Dry Eye, Ocular Allergies, Rosacea, Uveitis, Age-related Macular Degeneration, Diabetic Retinopathy, and Posterior Uveitis. Their products provide tailored formulations for precise delivery, addressing limitations of traditional treatments.Iolyx Therapeutics generates revenue through direct sales of its proprietary therapeutics to healthcare providers and institutions specializing in ocular health. The company collaborates with medical providers and distributors to ensure product accessibility. Additionally, the company aims to expand into autoimmune-related retinal diseases, targeting broader market access and product offerings in the coming years.
Who invested in Iolyx Therapeutics
2 investors across 1 round
See all investors in Iolyx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 3, 2025
Amount
$15M
Investors
Questions about Iolyx Therapeutics
Who invested in Iolyx Therapeutics?
Iolyx Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iolyx Therapeutics raised?
Iolyx Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Iolyx Therapeutics last raise money?
Iolyx Therapeutics's most recent round on record is a Series B, in Dec 2025.
What does Iolyx Therapeutics do?
Founded in 2021 and headquartered in Burlingame, California, Iolyx Therapeutics, Inc.
Where is Iolyx Therapeutics headquartered?
Iolyx Therapeutics is headquartered in Burlingame, US.
Which VCs invest in companies like Iolyx Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Iolyx Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Iolyx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.